However, similar to SOD2, there was no significant correlation between Ara‐C sensitivity and total SIRT3 protein levels in primary AML samples (Fig 1E), suggesting the certain active form of SIRT3 but not the total protein amount is the ultimate determinant for SOD2 post‐translational modification. The gene discussed is SOD2; the disease is acute myeloid leukemia.